Grufity logo
Grufity logo

Latest FARALLON CAPITAL MANAGEMENT LLC Stock Portfolio

$21.68Billion | No. of Holdings #82

FARALLON CAPITAL MANAGEMENT LLC Performance

2026 Q2+20.84%
YTD+15.37%
2025+14.28%

About FARALLON CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings

FARALLON CAPITAL MANAGEMENT LLC is a hedge fund based in San Francisco, CA. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, FARALLON CAPITAL MANAGEMENT LLC reported an equity portfolio of $21.7 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of FARALLON CAPITAL MANAGEMENT LLC are RVMD, EA, BBIO. The fund has invested 11.7% of it's portfolio in REVOLUTION MEDICINES INC and 7.5% of portfolio in ELECTRONIC ARTS INC. <br><br> The fund managers got completely rid off SCHWAB CHARLES CORP (SCHW), ALPHABET INC (GOOG) and VISA INC (V) stocks. They significantly reduced their stock positions in WELLTOWER INC (WELL), PACIFIC BIOSCIENCES CALIF IN (PACB) and TEVA PHARMACEUTICAL INDS LTD (TEVA). FARALLON CAPITAL MANAGEMENT LLC opened new stock positions in PARABILIS MEDICINES INC, NOVARTIS AG (NVS) and WARBY PARKER INC (WRBY). The fund showed a lot of confidence in some stocks as they added substantially to ABIVAX SA, GUARDANT HEALTH INC (GH) and ALVOTECH (ALVO).
FARALLON CAPITAL MANAGEMENT LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$21.68Billion
  as of Aug 14, 2026

FARALLON CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500

Our best estimate is that FARALLON CAPITAL MANAGEMENT, L.L.C. made a return of 20.84% in the last quarter. In trailing 12 months, it's portfolio return was 28.73%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
parabilis medicines inc64,817,600
novartis ag56,889,400
warby parker inc25,121,500
kailera therapeutics inc24,233,000
axalta coating sys ltd16,357,200
biogen inc15,340,300
taysha gene therapies inc15,322,500
mobia med inc15,122,700
New stocks bought by FARALLON CAPITAL MANAGEMENT LLC

Additions

Ticker% Inc.
abivax sa6,000
guardant health inc3,927
alvotech1,332
immunovant inc275
rio tinto plc241
novo-nordisk a s234
vnet group inc219
maze therapeutics inc197
Additions to existing portfolio by FARALLON CAPITAL MANAGEMENT LLC

Reductions

Ticker% Reduced
welltower inc-99.5
pacific biosciences calif in-89.48
teva pharmaceutical inds ltd-88.7
beta bionics inc-83.51
rani therapeutics hldgs inc-73.46
geron corp-66.51
netease com inc-57.59
microsoft corp-52.54
FARALLON CAPITAL MANAGEMENT LLC reduced stake in above stock

Sold off

Ticker$ Sold
centessa pharmaceuticals plc-191,013,000
schwab charles corp-371,753,000
tyra biosciences inc-137,145,000
disney walt co-231,465,000
vaxcyte inc-73,276,700
opus genetics inc-4,550,000
alphabet inc-285,779,000
visa inc-254,096,000
FARALLON CAPITAL MANAGEMENT LLC got rid off the above stocks

Sector Distribution

FARALLON CAPITAL MANAGEMENT, L.L.C. has about 64.8% of it's holdings in Healthcare sector.

  • Healthcare
  • Communication Services
  • Technology
  • Others
  • Financial Services
  • Consumer Cyclical
  • Industrials
Sector%
Healthcare64.8
Communication Services9.6
Technology7.2
Others6.9
Financial Services4.9
Consumer Cyclical3.8
Industrials2.6

Market Cap. Distribution

FARALLON CAPITAL MANAGEMENT, L.L.C. has about 68.7% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • MID-CAP
  • MEGA-CAP
  • UNALLOCATED
Category%
LARGE-CAP53
MID-CAP23.5
MEGA-CAP15.7
UNALLOCATED6.9

Stocks belong to which Index?

About 77.2% of the stocks held by FARALLON CAPITAL MANAGEMENT, L.L.C. either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • S&P 500
  • Others
Index%
RUSSELL 200042.8
S&P 50034.4
Others22.8
Top 5 Winners (%)%
RVMD
revolution medicines inc
440.2 %
LQDA
liquidia corporation
109.4 %
RVMD
revolution medicines inc
92.4 %
TWST
twist bioscience corp
81.4 %
brightspring health svcs inc
60.3 %
Top 5 Winners ($)$
RVMD
revolution medicines inc
1222.4 M
LQDA
liquidia corporation
357.4 M
UNH
unitedhealth group inc
224.2 M
LNTH
lantheus hldgs inc
195.9 M
NTRA
natera inc
193.9 M
Top 5 Losers (%)%
aleanna inc
-65.0 %
aleanna inc
-63.0 %
SLDP
solid power inc
-53.1 %
blue gold ltd
-37.0 %
BSX
boston scientific corp
-28.7 %
Top 5 Losers ($)$
BSX
boston scientific corp
-180.5 M
KKR
kkr & co inc
-3.2 M
astrazeneca plc
-3.0 M
NERV
minerva neurosciences inc
-1.1 M
aleanna inc
-0.5 M

FARALLON CAPITAL MANAGEMENT LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC

FARALLON CAPITAL MANAGEMENT, L.L.C. has 82 stocks in it's portfolio. About 43.9% of the portfolio is in top 10 stocks. BSX proved to be the most loss making stock for the portfolio. RVMD was the most profitable stock for FARALLON CAPITAL MANAGEMENT, L.L.C. last quarter.

$17.08BTotal Value
189Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of FARALLON CAPITAL MANAGEMENT LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ALVO
Alvotech

Alvotech

ALVO
FARALLON CAPITAL MANAGEMENT LLC's holding in Alvotech over time
0.05%2,859,680
$10.55M
0.05%
increased 1332.16 percentadded